Stock Report

Download full stock data and analysis for free Last Updated: 31-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Vikram Thermo Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 530477

₹300.10

up-down-arrow ₹5.05 (1.71%)

As on 31-Aug-2026 09:59IST

Market cap

info icon

₹925 Cr

Revenue (TTM)

info icon

₹144 Cr

P/E Ratio

info icon

21.1

P/B Ratio

info icon

5.4

Div. Yield

info icon

0.4 %

Edit peer-selector-edit
Vikram Thermo Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Market cap (₹ Cr)
 925 32,104 29,892 29,103 26,871
Revenue (₹ Cr)
 144 3,564 1,936 9,205 1,462
Net Profit (₹ Cr)
 43.84 414.00 288.22 -371.81 387.35
Net Margin (%)
 29.86 11.23 14.79 -3.93 26.01
RoE (%)
 29.80 8.38 29.77 -3.85 25.18
Price to Earnings
 21.11 78.49 103.71 -- 69.57
Price-To-Book
 5.44 6.38 22.27 3.64 15.55

Income Statement (₹ Cr)

Vikram Thermo Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Operating Revenue arrow
144.30 3,564.00 1,935.80 9,205.28 1,461.80
Total Income arrow
146.79 3,686.00 1,948.58 9,449.59 1,489.25
Total Expenditure arrow
83.70 2,792.00 1,485.56 8,195.15 919.25
EBITDA arrow
60.60 772.00 450.24 1,010.13 542.56
Depreciation arrow
3.15 226.00 50.83 857.51 37.68
EBIT arrow
57.46 546.00 399.41 152.62 504.88
Interest arrow
0.45 217.00 40.84 342.73 3.77
Other Income arrow
2.49 122.00 12.78 244.31 27.45
Exceptional Items arrow
0.00 12.00 0.00 -216.88 0.00
Profit before Tax arrow
59.49 463.00 371.35 -162.68 528.56
Provision for Tax arrow
15.65 49.00 83.14 209.13 141.21
Profit after Tax arrow
43.84 414.00 288.22 -371.81 387.35

Liabilities (₹ Cr)

Vikram Thermo Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Shareholder's Funds arrow
156.87 4,940.00 1,288.82 8,162.62 1,653.56
Minority Interest arrow
0.00 -5.00 0.00 0.00 -1.13
Non-Current Liabilities arrow
5.26 1,712.00 202.03 5,044.14 42.40
Current Liabilities arrow
25.78 1,622.00 835.87 4,758.28 230.82
Total Liabilities arrow
171.51 8,100.00 1,451.43 15,513.53 1,549.26

Assets (₹ Cr)

Vikram Thermo Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Non-Current Assets arrow
57.07 5,343.00 519.60 10,211.52 1,026.85
Current Assets arrow
85.04 2,606.00 1,681.81 7,191.66 881.27
Total Assets arrow
171.51 8,100.00 1,451.43 15,513.53 1,549.26
Total Debt* arrow
6.40 1,859.00 393.17 4,720.27 8.18
Net Current Assets arrow
59.27 984.00 845.94 2,433.38 650.46
Contingent Liabilities arrow
38.78 770.26 12.25 99.76 15.38

Cashflow (₹ Cr)

Vikram Thermo Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Cash From Operating Activities arrow
23.64 -22.00 159.18 892.30 118.34
Cash Flow from Investing Activities arrow
-22.40 -783.00 -64.81 -477.46 -223.94
Cash from Financing Activities arrow
-3.96 409.00 -39.81 -440.83 261.12
Net Cash Inflow / Outflow arrow
-2.72 -396.00 54.56 -25.99 155.52

Ratios

Profitability Ratios

 Vikram Thermo Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
ROCE (%) arrow
36.29 4.07 26.97 6.61 20.14
ROE (%) arrow
29.80 8.38 29.77 -3.85 25.18
ROA (%) arrow
26.27 4.94 24.77 -2.21 21.93
EBIT Margin (%) arrow
39.82 15.32 20.63 1.66 34.54
Net Margin (%) arrow
29.86 11.23 14.79 -3.93 26.01
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Vikram Thermo Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Revenue Growth (%) arrow
16.66 18.37 46.65 0.78 40.90
EBIT Growth (%) arrow
39.44 252.26 62.13 -70.53 124.50
Net Profit Growth (%) arrow
37.29 377.85 89.49 -1,383.43 104.15
EPS Growth (%) arrow
33.61 1,001.33 78.60 -484.84 42.32
Book Value Growth (%) arrow
6.98 29.77 42.49 2.28 94.96

Valuation Ratios

 Vikram Thermo Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Price / Earnings arrow
21.11 80.56 102.12 -93.01 69.57
Price / Book Value arrow
5.44 6.38 22.27 3.64 15.55
Dividend Yield (%) arrow
0.42 0.00 0.08 0.00 0.08
EV/EBITDA arrow
15.36 43.48 66.20 32.91 49.08
Market Cap (₹ Cr) arrow
548.45 23,064.69 0.00 29,731.27 19,988.69

Solvency Ratios

 Vikram Thermo Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Debt to Equity arrow
0.02 0.31 0.11 0.53 0.01
Short term debt to equity ratio arrow
0.01 0.11 0.54 0.12 0.02
Current Ratio arrow
3.30 1.61 2.01 1.51 3.82
Quick Ratio arrow
2.90 1.06 1.14 0.87 2.82
Interest Coverage arrow
132.03 3.13 10.09 0.53 141.16

Operating Efficiency Ratios

 Vikram Thermo Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Debtors to sales (%) arrow
31.86 16.50 26.28 23.44 24.80
Asset Turnover arrow
0.86 0.43 1.66 0.55 0.83
Receivable days arrow
120.80 60.36 47.59 77.05 90.06
Inventory Days arrow
36.58 64.42 62.58 77.13 61.02
Payable days arrow
82.35 218.94 228.78 173.49 96.06
Cash Conversion Cycle arrow
75.02 -94.15 -118.62 -19.30 55.02
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...